Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
49 studies found for:    Trigeminal Neuralgia
Show Display Options
Rank Status Study
21 Completed EEG Monitoring to Assess Emergence From Neuroanesthesia
Conditions: Cerebral Aneurysm;   Trigeminal Neuralgia
Interventions: Device: On-line EEG monitoring during neurosurgery;   Device: EEGo vs BIS
22 Recruiting PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants
Condition: Trigeminal Neuralgia
Interventions: Drug: BIIB074;   Drug: Placebo
23 Recruiting PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers
Condition: Trigeminal Neuralgia
Interventions: Drug: CNV1014802;   Drug: Placebo
24 Not yet recruiting New Formulation and Food Effect Study of BIIB074
Conditions: Trigeminal Neuralgia (TN);   Other Neuropathic Pain
Interventions: Drug: BIIB074 Treatment A;   Drug: BIIB074 Treatment B;   Drug: BIIB074 Treatment C;   Drug: BIIB074 Treatment D
25 Recruiting An Follow-up Study of Occlusal Adjustment for Orofacial Pain
Conditions: Orofacial Pain;   Trigeminal Neuralgia
Intervention: Other: occlusal adjustment
26 Withdrawn Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception
Conditions: Pain;   Trigeminal Neuralgia;   Neuropathic Pain
Interventions: Device: laboratory pain assessment;   Procedure: transcranial magnetic stimulation
27 Completed Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain
Conditions: Facial Neuralgia;   Pain;   Trigeminal Neuralgia
Intervention: Drug: Dextromethorphan
28 Enrolling by invitation RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Conditions: Neoplasms;   Arteriovenous Malformation of Central Nervous System;   Trigeminal Neuralgia
Intervention: Radiation: SRS/SBRT
29 Completed Hippocampal Radiation Exposure and Memory
Conditions: Arteriovenous Malformation;   Schwannoma;   Trigeminal Neuralgia
Intervention:
30 Withdrawn Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain
Conditions: Atypical Facial Pain;   Persistent Idiopathic Facial Pain;   Atypical Trigeminal Neuralgia;   Neuropathic Orofacial Pain;   Neuropathic Facial Pain
Interventions: Drug: ATNC05;   Drug: Placebo
31 Completed Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain
Conditions: Typical Facial Pain;   Atypical Facial Pain
Interventions: Drug: Bupivacaine;   Drug: Triamcinolone;   Drug: Dexamethasone
32 Completed A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain
Conditions: Diabetes Mellitus;   Neuropathic Pain
Intervention: Drug: Botulinum Toxin Type A
33 Recruiting Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy
Conditions: Postoperative Quality of Recovery;   Postoperative Migrainous Headache
Interventions: Drug: Sumatriptan;   Drug: Placebo
34 Withdrawn CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
Conditions: Cranial Nerve Diseases;   Facial Neuralgia;   Trigeminal Neuralgia;   Hemifacial Spasm
Interventions: Procedure: prophylactic spinal tap;   Procedure: no prophylactic spinal tap
35 Completed Comparative Study Between Levobupivacaine and Bupivacaine for Nerve Block During Pediatric Primary Cleft Palate Surgery
Condition: Recovery After Cleft Palate Surgery
Intervention: Procedure: Bilateral Suprazygomatic MNB
36 Recruiting HBOT Late Radiation Tissue Injury
Conditions: Late Radiation Injury;   Chronic Pain
Intervention:
37 Recruiting Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.
Conditions: Trigeminal Neuralgia (Burchiel Type I);   Trigeminal Neuralgia (Burchiel Type II);   Trigeminal Neuropathic Pain;   Trigeminal Deafferentation Pain;   Complex Regional Pain Syndrome (Types I and II, Involving the Upper Extremity);   Glossopharyngeal Neuralgia;   Upper Extremity Pain Due to Deafferentation of the Cervical Spine;   Central Pain Syndromes
Intervention: Device: Epidural Motor Cortex Stimulation
38 Completed
Has Results
A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®)
Condition: Malaria
Intervention: Drug: COA566
39 Terminated Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve
Condition: Postherpetic Neuralgia
Interventions: Drug: Civamide Nasal Spray;   Drug: Placebo
40 Completed Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain
Conditions: Healthy Volunteers;   Patients Suffering of Peripheral Neuropathic Pain
Intervention: Other: Neuropathic pain

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-49) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.